Invention Grant
- Patent Title: Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
-
Application No.: US15540344Application Date: 2015-12-30
-
Publication No.: US11712407B2Publication Date: 2023-08-01
- Inventor: Yoon Sung Nam , Sung Duk Jo , Bon Il Koo
- Applicant: CELLTRION, INC. , KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Incheon
- Assignee: CELLTRION, INC.,Korea Advanced institute of Science and Technology
- Current Assignee: CELLTRION, INC.,Korea Advanced institute of Science and Technology
- Current Assignee Address: KR Incheon; KR Daejeon
- Agency: MaxGoLaw PLLC
- Priority: KR 20140193921 2014.12.30
- International Application: PCT/KR2015/014504 2015.12.30
- International Announcement: WO2016/108634A 2016.07.07
- Date entered country: 2018-01-29
- Main IPC: A61K8/14
- IPC: A61K8/14 ; A61Q19/00 ; A61K8/55 ; A61Q19/08 ; A61K9/00 ; A61K9/127 ; A61K8/64
Abstract:
The present invention relates to a hybrid-type multi-lamellar nanostructure of an epidermal growth factor and a liposome and a method for manufacturing same. The new type of hybrid-type multi-lamellar nanostructure not only has a high epidermal growth factor encapsulating efficiency, but also can be manufactured through a simple process, such that the same can be easily delivered into a living body or a cell while maintaining a high physiological activity of the epidermal growth factor.
Public/Granted literature
Information query
